Carglumic acid
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68475-006 -
Package NDC
68475-006-01 -
Package NDC
68475-006-02 -
Application number
ANDA213395 -
SPL ID
55e79bd0-56bd-4095-aa7e-942b3e5c1b40 -
SPL set ID
59e73eb8-edf8-4fad-93c2-deb6b23497f8 -
UNII
5L0HB4V1EW -
RxCUI
905390
What the source publishes
- Labeler
- Navinta LLC
- Active ingredients
- Carglumic acid
- Form
- TABLET, FOR SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Carglumic acid",
"splId": "55e79bd0-56bd-4095-aa7e-942b3e5c1b40",
"labels": [
{
"setId": "59e73eb8-edf8-4fad-93c2-deb6b23497f8",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59e73eb8-edf8-4fad-93c2-deb6b23497f8",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59e73eb8-edf8-4fad-93c2-deb6b23497f8"
}
],
"routes": [
"ORAL"
],
"labeler": "Navinta LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "5 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-01)",
"package_ndc": "68475-006-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220801"
},
{
"sample": false,
"description": "60 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-02)",
"package_ndc": "68475-006-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20220801"
}
],
"productId": "68475-006_55e79bd0-56bd-4095-aa7e-942b3e5c1b40",
"useDomain": "unknown",
"dosageForm": "TABLET, FOR SUSPENSION",
"productNdc": "68475-006",
"deaSchedule": null,
"genericName": "Carglumic acid",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CARGLUMIC ACID",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA213395",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220801",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000184144",
"N0000184143"
],
"unii": [
"5L0HB4V1EW"
],
"rxcui": [
"905390"
],
"spl_set_id": [
"59e73eb8-edf8-4fad-93c2-deb6b23497f8"
],
"pharm_class_epc": [
"Carbamoyl Phosphate Synthetase 1 Activator [EPC]"
],
"pharm_class_moa": [
"Carbamoyl Phosphate Synthetase 1 Activators [MoA]"
],
"manufacturer_name": [
"Navinta LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68475-006_55e79bd0-56bd-4095-aa7e-942b3e5c1b40"